- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01755962
Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity (GET FIT)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
California
-
Los Angeles, California, Förenta staterna, 90095
- University of California, Los Angeles
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- 18-35 with BMI≥30 and/or your waist circumference ≥40 inches for males or ≥35 inches for females
- In good health as determined by the screening visit and review of medical history
Exclusion Criteria:
- Have a known heart arrhythmia and/or abnormalities found in electrocardiogram (ECG) reading or use of medications that influence CV function
- Have been in a weight loss or exercise program in the 6 months prior to participation
- Use tobacco products
- Have a syndrome or are prescribed medications that may influence body composition, insulin action, or CVD (e.g. PCOS, prednisone, methylphenidate, etc.)
- Have intolerance to lactose or gluten
- Pregnant
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Low Glycemic Load + Resistance Training
12-week intervention diet + resistance training (1 hour, 3 times per week)
|
|
|
Experimentell: High Glycemic Load + Resistance Training
12-week control diet + resistance training (1 hour, 3 times per week)
|
|
|
Experimentell: Low Glycemic Load
12-week intervention diet
|
|
|
Övrig: High Glycemic Load
12-week control diet
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Endothelial function as determined by brachial artery FMD
Tidsram: 12 weeks
|
12 weeks
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
monocyte inflammation
Tidsram: 12 weeks
|
12 weeks
|
|
Insulin Sensitivity by Oral Glucose Tolerance Test
Tidsram: 12 weeks
|
12 weeks
|
|
MAGE via Continuous Glucose Monitoring System
Tidsram: 12 weeks
|
12 weeks
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
body composition (total fat mass, visceral fat, HFF, LBM) via DXA and MRI
Tidsram: 12 weeks
|
12 weeks
|
|
|
plasma and cellular biomarkers post pre and post 12 week intervention
Tidsram: 12 weeks
|
Monocytes will be isolated from subject whole blood and will be phenotyped in 2 ways: 1) as pro- or anti-inflammatory based on flow-activated cell sorting (FACS) analysis of monocyte-specific markers TLR-4, CD14 and CD16. Serum-Stimulated Cell Culture. Subject serum will be incubated with L6 cells as we have previously performed in monocytes and adipocytes as well as endothelial cells 18, 130. Following 48 hr incubation, cellular insulin-stimulated glucose transport will be assayed as described 129 and conditioned medium assayed for myokine levels (ex. IL-15, 1L-6, etc). Fasting plasma (and conditioned media where appropriate) will be taken to determine a panel of adipokines and hormones (e.g. insulin, adiponectin, HSP-72, IL-4, IL-6, IL-10, MCP-1, CRP, 8-iso PGF2α) will be measured using the Millipore Multiplex assay kit or with specific ELISA kits |
12 weeks
|
|
RNA/protein levels via muscle and fat tissue collection
Tidsram: 12 weeks
|
Approximately 300 mg of muscle tissue from the superficial portion of the vastus lateralis and approximately 3-5 g of subcutaneous adipose tissue from the periumbilical portion of the abdomen will be obtained.
|
12 weeks
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Catherine Carpenter, PhD, MPH, University of California, Los Angeles
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 546464
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .